Atherosclerosis in LDLR-Knockout Mice Is Inhibited, but Not Reversed, by the PPARγ Ligand Pioglitazone

Thiazolidinediones, a class of drugs for the treatment of type-2 diabetes, are synthetic ligands for peroxisome proliferator-activated receptor-γ. They have been demonstrated to possess cardioprotective effects in humans and anti-atherogenic properties in animal models. However, the question remains...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nakaya, Hideaki, Summers, Barbara D., Nicholson, Andrew C., Gotto, Antonio M., Hajjar, David P., Han, Jihong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Investigative Pathology 2009
Gaiak:
Short Communications
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2684166/
https://ncbi.nlm.nih.gov/pubmed/19435790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2009.080611
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak